Citations (102)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Panayiotis D. Ziakas, Loukia S. Poulou, Michael Voulgarelis & Loukas Thanos. (2012) The Gordian knot of interim 18-fluorodeoxyglucose positron emission tomography for Hodgkin lymphoma: a meta-analysis and commentary on published studies. Leukemia & Lymphoma 53:11, pages 2166-2174.
Read now
Read now
Barry L. Shulkin, Geoffrey S. Goodin, Mary B. McCarville, Sue C. Kaste, Matthew J. Krasin, Melissa M. Hudson & Monika Metzger. (2009) Bone and [18F]Fluorodeoxyglucose positron-emission tomography/computed tomography scanning for the assessment of osseous involvement in Hodgkin lymphoma in children and young adults. Leukemia & Lymphoma 50:11, pages 1794-1802.
Read now
Read now
Martin Hutchings. (2009) PET imaging in lymphoma. Expert Review of Hematology 2:3, pages 261-276.
Read now
Read now
Jonathan Friedberg, Eric Jacobsen, Donna Neuberg, Jeffrey Kutok, Olivier Munoz, Vassiliki Boussiotis, Hazel Reynolds, David Fisher, Agnieszka Szot, Annick Van Den Abbeele & Arnold Freedman. (2008) Targeting the follicular lymphoma microenvironment through blockade of TNFα with etanercept. Leukemia & Lymphoma 49:5, pages 902-909.
Read now
Read now
Aaron Polliack, Koen van Besien & John F. Seymour. (2008) 2007: The year in review for Leukemia and Lymphoma. Leukemia & Lymphoma 49:1, pages 1-3.
Read now
Read now
Jinhua Zhao, Wenli Qiao, Chun Wang, Taisong Wang & Yan Xing. (2007) Therapeutic evaluation and prognostic value of interim hybrid PET/CT with 18F-FDG after three to four cycles of chemotherapy in non-Hodgkin's lymphoma. Hematology 12:5, pages 423-430.
Read now
Read now
Lieselot Brepoels, Sigrid Stroobants, Walter de Wever, Karoline Spaepen, Peter Vandenberghe, Jose Thomas, Anne Uyttebroeck, Luc Mortelmans, Christiane de Wolf-Peeters & Gregor Verhoef. (2007) Hodgkin lymphoma: Response assessment by Revised International Workshop Criteria. Leukemia & Lymphoma 48:8, pages 1539-1547.
Read now
Read now
Rajen J. Mody, Chuong Bui, Raymond J. Hutchinson, Kirk A. Frey & Barry L. Shulkin. (2007) Comparison of 18F Flurodeoxyglucose PET with Ga-67 scintigraphy and conventional imaging modalities in pediatric lymphoma. Leukemia & Lymphoma 48:4, pages 699-707.
Read now
Read now
Lieselot Brepoels, Sigrid Stroobants & Gregor Verhoef. (2007) PET and PET/CT for response evaluation in lymphoma: Current practice and developments. Leukemia & Lymphoma 48:2, pages 270-282.
Read now
Read now
Articles from other publishers (93)
Akram Al-Ibraheem, Felix M Mottaghy & Malik E. Juweid. (2023) PET/CT in Hodgkin Lymphoma: An Update. Seminars in Nuclear Medicine 53:3, pages 303-319.
Crossref
Crossref
Akiyo Tanaka, Nikki Maples-Reynolds & Bruce A. Fowler. 2022. Handbook on the Toxicology of Metals. Handbook on the Toxicology of Metals
275
288
.
Nicola M. Hughes, Heather A. Jacene, Sree Harsha Tirumani & Richard L. Wahl. 2020. Nuclear Oncology. Nuclear Oncology
1
45
.
Nicola M. Hughes, Heather A. Jacene, Sree Harsha Tirumani & Richard L. Wahl. 2022. Nuclear Oncology. Nuclear Oncology
431
474
.
N Ari Wijetunga, Brandon Stuart Imber, James F Caravelli, N George Mikhaeel & Joachim Yahalom. (2021) A picture is worth a thousand words: a history of diagnostic imaging for lymphoma. The British Journal of Radiology 94:1127.
Crossref
Crossref
Melanie M. Hagleitner, Monika L. Metzger, Jamie E. Flerlage, Kara M. Kelly, Stephan D. Voss, Regine Kluge, Lars Kurch, Steve Cho, Christine Mauz‐Koerholz & Auke Beishuizen. (2020) Liver involvement in pediatric Hodgkin lymphoma: A systematic review by an international collaboration on Staging Evaluation and Response Criteria Harmonization (SEARCH) for Children, Adolescent, and Young Adult Hodgkin Lymphoma (CAYAHL). Pediatric Blood & Cancer 67:8.
Crossref
Crossref
Angela Aldin, Lisa Umlauff, Lise J Estcourt, Gary Collins, Karel GM Moons, Andreas Engert, Carsten Kobe, Bastian von Tresckow, Madhuri Haque, Farid Foroutan, Nina Kreuzberger, Marialena Trivella & Nicole Skoetz. (2020) Interim PET-results for prognosis in adults with Hodgkin lymphoma: a systematic review and meta-analysis of prognostic factor studies. Cochrane Database of Systematic Reviews 2020:8.
Crossref
Crossref
Angela Aldin, Lisa Umlauff, Lise J Estcourt, Gary Collins, Karel GM Moons, Andreas Engert, Carsten Kobe, Bastian von Tresckow, Madhuri Haque, Farid Foroutan, Nina Kreuzberger, Marialena Trivella & Nicole Skoetz. (2019) Interim PET-results for prognosis in adults with Hodgkin lymphoma: a systematic review and meta-analysis of prognostic factor studies. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Jan Maciej Zaucha, Stephane Chauvie, Renata Zaucha, Alberto Biggii & Andrea Gallamini. (2019) The role of PET/CT in the modern treatment of Hodgkin lymphoma. Cancer Treatment Reviews 77, pages 44-56.
Crossref
Crossref
Paola Anna Erba, Martina Sollini, Roberto Boni & Sara Galimberti. 2019. Nuclear Medicine Textbook. Nuclear Medicine Textbook
655
705
.
Tarec Christoffer El-Galaly, Lars Christian Gormsen & Martin Hutchings. (2018) PET/CT for Staging; Past, Present, and Future. Seminars in Nuclear Medicine 48:1, pages 4-16.
Crossref
Crossref
J.M. Zaucha, B. Małkowski, S. Chauvie, E. Subocz, J. Tajer, W. Kulikowski, A. Fijołek-Warszewska, A. Biggi, F. Fallanca, M. Kobylecka, M. Dziuk, D. Woszczyk, J. Rybka, R. Kroll-Balcerzak, F. Bergesio, A. Romanowicz, A. Chamier-Ciemińska, P. Kurczab, A. Giza, K. Leśniewski-Kmak, R. Zaucha, D. Świetlik, T. Wróbel, W. Knopińska-Posłuszny, J. Walewski & A. Gallamini. (2017) The predictive role of interim PET after the first chemotherapy cycle and sequential evaluation of response to ABVD in Hodgkin’s lymphoma patients—the Polish Lymphoma Research Group (PLRG) Observational Study. Annals of Oncology 28:12, pages 3051-3057.
Crossref
Crossref
Chadwick L. Wright, Joseph J. Maly, Jun Zhang & Michael V. Knopp. (2017) Advancing Precision Nuclear Medicine and Molecular Imaging for Lymphoma. PET Clinics 12:1, pages 63-82.
Crossref
Crossref
Shao-Li Song, Pan-Li Li & Gang Huang. 2017. Personalized Pathway-Activated Systems Imaging in Oncology. Personalized Pathway-Activated Systems Imaging in Oncology
213
222
.
Heather A. Jacene, Sree Harsha Tirumani & Richard L. Wahl. 2017. Nuclear Oncology. Nuclear Oncology
353
393
.
Andrea K. Ng, Lawrence M. Weiss & Ann S. LaCasce. 2016. Clinical Radiation Oncology. Clinical Radiation Oncology
1506
1523.e5
.
Kenneth B. Roberts, Kara M. Kelly & Louis S. Constine. 2016. Clinical Radiation Oncology. Clinical Radiation Oncology
1464
1485.e5
.
Deborah F. Billmire. 2016. The Surgery of Childhood Tumors. The Surgery of Childhood Tumors
383
394
.
Heather A. Jacene, Sree Harsha Tirumani & Richard L. Wahl. 2016. Nuclear Oncology. Nuclear Oncology
1
42
.
Colette J. Shen & Stephanie A. Terezakis. 2020. Controversies in Radiation Oncology. Controversies in Radiation Oncology
191
210
.
Bruce A. Fowler & Mary J. Sexton. 2015. Handbook on the Toxicology of Metals. Handbook on the Toxicology of Metals
787
797
.
Paul Fields. 2015. Management of Hematological Cancer in Older People. Management of Hematological Cancer in Older People
169
183
.
Lale Kostakoglu & Bruce D. Cheson. (2014) Current role of FDG PET/CT in lymphoma. European Journal of Nuclear Medicine and Molecular Imaging 41:5, pages 1004-1027.
Crossref
Crossref
I-Hong Shih, Xu-Dong Duan, Fan-Lin Kong, Michael D. Williams, Kevin Yang, Yin-Han Zhang & David J. Yang. (2014)
Automated Synthesis of
18
F-Fluoropropoxytryptophan for Amino Acid Transporter System Imaging
. BioMed Research International 2014, pages 1-11.
Crossref
Crossref
Paolo G. Gobbi, Andrés J.M. Ferreri, Maurilio Ponzoni & Alessandro Levis. (2013) Hodgkin lymphoma. Critical Reviews in Oncology/Hematology 85:2, pages 216-237.
Crossref
Crossref
Fan-Lin Kong, Richard J. Ford & David J. Yang. (2013) Managing Lymphoma with Non-FDG Radiotracers: Current Clinical and Preclinical Applications. BioMed Research International 2013, pages 1-12.
Crossref
Crossref
Heather A. Jacene & Richard L. Wahl. 2013. Nuclear Oncology. Nuclear Oncology
153
187
.
Oguz Akin, Sandra B. Brennan, D. David Dershaw, Michelle S. Ginsberg, Marc J. Gollub, Heiko Schöder, David M. Panicek & Hedvig Hricak. (2012) Advances in oncologic imaging. CA: A Cancer Journal for Clinicians 62:6, pages 364-393.
Crossref
Crossref
Stephanie A. Terezakis & Yvette L. Kasamon. (2012) Tailored strategies for radiation therapy in classical Hodgkin's lymphoma. Critical Reviews in Oncology/Hematology 84:1, pages 71-84.
Crossref
Crossref
Jakub Svoboda & Stephen J. Schuster. (2012) The Evolving Role of Medical Imaging in Lymphoma Management: The Clinician’s Perspective. PET Clinics 7:1, pages 35-46.
Crossref
Crossref
Andrea K. Ng & Peter Mauch. 2012. Clinical Radiation Oncology. Clinical Radiation Oncology
1521
1525
.
Andrea K. Ng, Lawrence Weiss & Ann S. LaCasce. 2012. Clinical Radiation Oncology. Clinical Radiation Oncology
1527
1543
.
Kenneth B. Roberts, Melissa M. Hudson & Louis S. Constine. 2012. Clinical Radiation Oncology. Clinical Radiation Oncology
1489
1503
.
Erika Ramsdale, Koen van Besien & Sonali M. Smith. (2011) Personalized Treatment of Lymphoma: Promise and Reality. Seminars in Oncology 38:2, pages 225-235.
Crossref
Crossref
Yvette L. Kasamon. (2011) Prognostication and Risk-Adapted Therapy of Hodgkin's Lymphoma Using Positron Emission Tomography. Advances in Hematology 2011, pages 1-12.
Crossref
Crossref
Martin Hutchings, Anne Kiil Berthelsen & Sally F. Barrington. 2011. Radiotherapy for Hodgkin Lymphoma. Radiotherapy for Hodgkin Lymphoma
81
89
.
Malik E. Juweid. 2011. Positron Emission Tomography. Positron Emission Tomography
1
19
.
Joseph J. Junewick & Paul Shreve. 2011. Clinical PET-CT in Radiology. Clinical PET-CT in Radiology
369
385
.
Chung K. Lee & Philip Poortmans. 2012. Technical Basis of Radiation Therapy. Technical Basis of Radiation Therapy
1099
1140
.
Andrew M. Evens & Sandra J. Horning. 2011. Management of Hematologic Malignancies. Management of Hematologic Malignancies
367
403
.
Nina Arakelyan, Jean‐Philippe Jais, Vincent Delwail, Josette Brière, Marie‐Pierre Moles‐Moreau, Delphine Sénécal, Christian Berthou, Bernard Desablens, Pierre Colonna & Jean‐Marie Andrieu. (2010) Reduced versus full doses of irradiation after 3 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine in early stage Hodgkin lymphomas. Cancer 116:17, pages 4054-4062.
Crossref
Crossref
Alfred Ian Lee, Dan S. Zuckerman, Annick D. Van den Abbeele, Suzanne L. Aquino, Diane Crowley, Christiana Toomey, Ann S. Lacasce, Yang Feng, Donna S. Neuberg & Ephraim P. Hochberg. (2010) Surveillance imaging of Hodgkin lymphoma patients in first remission. Cancer 116:16, pages 3835-3842.
Crossref
Crossref
Zsuzsa Molnár, Zsófia Simon, Zita Borbényi, Beáta Deák, LászLÓ Galuska, Kármen Keresztes, Zsófia Miltényi, Imelda Marton, András Rosta, Tamás Schneider, Lajos Trón, Erika Várady & Árpád Illés. (2009) Prognostic value of FDG-PET in Hodgkin lymphoma for posttreatment evaluation. Long-term follow-up results. Orvosi Hetilap 150:47, pages 2133-2138.
Crossref
Crossref
Yiyan Liu. (2009) Clinical significance of diffusely increased splenic uptake on FDG-PET. Nuclear Medicine Communications 30:10, pages 763-769.
Crossref
Crossref
Teruhiko TerasawaJoseph LauStéphane BardetOlivier CouturierTomomitsu HottaMartin HutchingsTakashi NihashiHirokazu Nagai. (2009) Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography for Interim Response Assessment of Advanced-Stage Hodgkin's Lymphoma and Diffuse Large B-Cell Lymphoma: A Systematic Review. Journal of Clinical Oncology 27:11, pages 1906-1914.
Crossref
Crossref
C. Ramos-Font, Á.C. Rebollo Aguirre, R. Villegas Portero, A. Romero Tabares, M. Gallego Peinado & J.M. Llamas Elvira. (2009) Tomografía de positrones con 18F-fluorodesoxiglucosa en la valoración de la respuesta de los linfomas al tratamiento. Revisión sistemática de la literatura y metaanálisis. Revista Española de Medicina Nuclear 28:2, pages 48-55.
Crossref
Crossref
Mary K. Gospodarowicz. (2009) Hodgkin’s Lymphoma—Patients Assessment and Staging. The Cancer Journal 15:2, pages 138-142.
Crossref
Crossref
C. Ramos-Font, Á.C. Rebollo Aguirre, R. Villegas Portero, A. Romero Tabares, M. Gallego Peinado & J.M. Llamas Elvira. (2009) 18F-fluorodeoxyglucose positron emission tomography in the evaluation of therapy response assessment in lymphomas. Systematic literature review and meta-analysis. Revista Española de Medicina Nuclear (English Edition) 28:2, pages 48-55.
Crossref
Crossref
Voichita Bar Ad, Ora Paltiel & Eli Glatstein. (2008) Radiotherapy for Early-Stage Hodgkin's Lymphoma: A 21st Century Perspective and Review of Multiple Randomized Clinical Trials. International Journal of Radiation Oncology*Biology*Physics 72:5, pages 1472-1479.
Crossref
Crossref
Rebecca L. Elstrom & John P. Leonard. (2008) FDG-PET scans in patients with lymphoma. Current Hematologic Malignancy Reports 3:4, pages 197-203.
Crossref
Crossref
Andrew M Evens, Martin Hutchings & Volker Diehl. (2008) Treatment of Hodgkin lymphoma: the past, present, and future. Nature Clinical Practice Oncology 5:9, pages 543-556.
Crossref
Crossref
Melissa Hines-Thomas, Sue C. Kaste, Melissa M. Hudson, Scott C. Howard, Wei A. Liu, Jianrong Wu, Larry E. Kun, Barry L. Shulkin, Matthew J. Krasin & Monika L. Metzger. (2008) Comparison of gallium and PET scans at diagnosis and follow-up of pediatric patients with Hodgkin lymphoma. Pediatric Blood & Cancer 51:2, pages 198-203.
Crossref
Crossref
Martin Hutchings & Lena Specht. (2008) PET/CT in the management of haematological malignancies. European Journal of Haematology 80:5, pages 369-380.
Crossref
Crossref
A. Re, S. Ferrari, P. Frata, C. Pizzocaro, C. Crippa, A. Tucci, F. Facchetti, L. Grazioli, S.M. Magrini & G. Rossi. (2008) Late computed tomography scan response improvement and gallium scintigraphy evaluation as on-treatment prognostic parameters to tailor treatment intensity in patients with Hodgkin's lymphoma. A prospective phase II study. Annals of Oncology 19:5, pages 951-957.
Crossref
Crossref
X. Cuenca & J. -E. Filmont. (2008) Critères des réponses thérapeutiques TEP dans les hémopathies lymphoïdesPET-scan criteria for the assessment of the therapeutic response in patients with lymphoma. Oncologie 10:5, pages 299-302.
Crossref
Crossref
Yvette L Kasamon & Richard L Wahl. (2008) FDG PET and risk-adapted therapy in Hodgkin's and non-Hodgkin's lymphoma. Current Opinion in Oncology 20:2, pages 206-219.
Crossref
Crossref
Heiko Schöder & Craig Moskowitz. (2008) PET Imaging for Response Assessment in Lymphoma: Potential and Limitations. Radiologic Clinics of North America 46:2, pages 225-241.
Crossref
Crossref
F. Montravers, C. de Bazelaire, K. Kerrou, C. Farges, V. Huchet, J-N Talbot, J. Frija & E. de Kerviler. (2008) Imagerie radiologique et TEP scanner des lymphomes de l’adulte et de l’enfant. Journal de Radiologie 89:3, pages 371-386.
Crossref
Crossref
F.A. Hampson & A.S. Shaw. (2008) Response assessment in lymphoma. Clinical Radiology 63:2, pages 125-135.
Crossref
Crossref
Teruhiko Terasawa, Takashi Nihashi, Tomomitsu Hotta & Hirokazu Nagai. (2008)
18
F-FDG PET for Posttherapy Assessment of Hodgkin's Disease and Aggressive Non-Hodgkin's Lymphoma: A Systematic Review
. Journal of Nuclear Medicine 49:1, pages 13-21.
Crossref
Crossref
Lale Kostakoglu. (2008) FDG-PET Evaluation of Response to Treatment. PET Clinics 3:1, pages 37-75.
Crossref
Crossref
Javier Altamirano, Jorge Reyes Esparza, Jaime de la Garza Salazar, Pedro Sobrevilla Calvo, Silvia Rivas Vera, Juan Ramón Chalapud Revelo & Gisela Estrada. (2008) Staging, Response to Therapy, and Restaging of Lymphomas with 18F-FDG PET. Archives of Medical Research 39:1, pages 69-77.
Crossref
Crossref
Michael Moore & Michael A. Blake. 2008. MDCT. MDCT
166
208
.
S. N. Reske. 2008. PET in Oncology. PET in Oncology
93
107
.
Deborah F. Billmire. 2008. The Surgery of Childhood Tumors. The Surgery of Childhood Tumors
305
317
.
Lieselot Brepoels & Sigrid Stroobants. (2007) Is [18F]fluorodeoxyglucose Positron Emission Tomography the Ultimate Tool for Response and Prognosis Assessment?. Hematology/Oncology Clinics of North America 21:5, pages 855-869.
Crossref
Crossref
Lena Specht. (2007) 2-[18F]Fluoro-2-Deoxyglucose Positron-Emission Tomography in Staging, Response Evaluation, and Treatment Planning of Lymphomas. Seminars in Radiation Oncology 17:3, pages 190-197.
Crossref
Crossref
Anna M. Kirby & N. George Mikhaeel. (2007) The role of FDG PET in the management of lymphoma: what is the evidence base?. Nuclear Medicine Communications 28:5, pages 335-354.
Crossref
Crossref
BRUCE A. FOWLER & MARY J. SEXTON. 2007. Handbook on the Toxicology of Metals. Handbook on the Toxicology of Metals
547
555
.
Melissa M. Hudson, Cindy Schwartz & Louis S. Constine. 2007. Pediatric Lymphomas. Pediatric Lymphomas
35
66
.
K. Namberger & R. Greil. (2006) The Role of Imaging in Malignant Lymphoma: A Critical View on PET Scanning in Current Clinical Practice. Imaging Decisions MRI 10:4, pages 22-31.
Crossref
Crossref
Jennifer M. Levine, Michael Weiner & Kara M. Kelly. (2006) Routine Use of PET Scans After Completion of Therapy in Pediatric Hodgkin Disease Results in a High False Positive Rate. Journal of Pediatric Hematology/Oncology 28:11, pages 711-714.
Crossref
Crossref
A.K. Ng, S. Li, D. Neuberg, D.C. Fisher, C. McMillan, B. Silver, K.C. Marcus, M.A. Stevenson & P.M. Mauch. (2006) Long-term results of a prospective trial of mantle irradiation alone for early-stage Hodgkin's disease. Annals of Oncology 17:11, pages 1693-1697.
Crossref
Crossref
J. Fuertes Manuel, M. Estorch Cabrera, V. Camacho Martí, A. Flotats Giralt, A.A. Rodríguez-Revuelto, M.A. Hernández Fructuoso & I. Carrió Gasset. (2006) Estudios SPECT-TAC con 67Ga de la enfermedad linfomatosa. Su aportación en la estadificación y seguimiento de la enfermedad. Revista Española de Medicina Nuclear 25:4, pages 242-249.
Crossref
Crossref
P.L. Zinzani, M. Tani, S. Fanti, L. Alinari, G. Musuraca, E. Marchi, V. Stefoni, P. Castellucci, M. Fina, M. Farshad, S. Pileri & M. Baccarani. (2006) Early positron emission tomography (PET) restaging: a predictive final response in Hodgkin's disease patients. Annals of Oncology 17:8, pages 1296-1300.
Crossref
Crossref
Elka Miller, Ur Metser, Galia Avrahami, Rina Dvir, Dalia Valdman, Liat Ben Sira, Dror Sayar, Yoav Burstein, Amos Toren, Isaac Yaniv & Einat Even-Sapir. (2006) Role of 18F-FDG PET/CT in Staging and Follow-up of Lymphoma in Pediatric and Young Adult Patients. Journal of Computer Assisted Tomography 30:4, pages 689-694.
Crossref
Crossref
N. George Mikhaeel. (2006) Use of FDG-PET to monitor response to chemotherapy and radiotherapy in patients with lymphomas. European Journal of Nuclear Medicine and Molecular Imaging 33:S1, pages 22-26.
Crossref
Crossref
Richard W. Tsang, David C. Hodgson & Michael Crump. (2006) Hodgkin’s Lymphoma. Current Problems in Cancer 30:3, pages 107-158.
Crossref
Crossref
Martin HutchingsAnnika LoftMads HansenLars Møller PedersenThora BuhlJesper JurlanderSimon BuusSusanne KeidingFrancesco D'AmoreAnne-Marie BoesenAnne Kiil BerthelsenLena Specht. (2006) FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma. Blood 107:1, pages 52-59.
Crossref
Crossref
Malik E. Juweid. (2006) Utility of Positron Emission Tomography (PET) Scanning in Managing Patients with Hodgkin Lymphoma. Hematology 2006:1, pages 259-265.
Crossref
Crossref
. 2006. The Lymphomas. The Lymphomas
476
499
.
Guy H. M. Jerusalem, Roland Hustinx & Pierre Rigo. 2006. Positron Emission Tomography. Positron Emission Tomography
125
145
.
Kazuki Fukuchi, Yoshio Ishida, Masahiro Higashi, Tomohiro Tsunekawa, Hitoshi Ogino, Kenji Minatoya, Keisuke Kiso & Hiroaki Naito. (2005) Detection of aortic graft infection by fluorodeoxyglucose positron emission tomography: Comparison with computed tomographic findings. Journal of Vascular Surgery 42:5, pages 919-925.
Crossref
Crossref
Guy Jerusalem, Roland Hustinx, Yves Beguin & Georges Fillet. (2005) Positron emission tomography imaging for lymphoma. Current Opinion in Oncology 17:5, pages 441-445.
Crossref
Crossref
Amir H. Khandani & Richard L. Wahl. (2005) Applications of PET in Liver Imaging. Radiologic Clinics of North America 43:5, pages 849-860.
Crossref
Crossref
M. Hutchings, N.G. Mikhaeel, P.A. Fields, T. Nunan & A.R. Timothy. (2005) Prognostic value of interim FDG-PET after two or three cycles of chemotherapy in Hodgkin lymphoma. Annals of Oncology 16:7, pages 1160-1168.
Crossref
Crossref
Guy Jerusalem, Roland Hustinx, Yves Beguin & Georges Fillet. (2005) Evaluation of Therapy for Lymphoma. Seminars in Nuclear Medicine 35:3, pages 186-196.
Crossref
Crossref
Ramaprasad Srinivasan, Armando Filie, James Reynolds, Richard Chang, Catherine Chow, David S. Schrump, Yoshiyuki Takahashi, Anthony F. Suffredini & Richard W. Childs. (2005) Positron Emission Tomography for Lymphoma Staging: Tissue Remains the Issue. JNCI: Journal of the National Cancer Institute 97:8, pages 611-613.
Crossref
Crossref
Smith Apisarnthanarax & K. S. Clifford Chao. (2005) Current Imaging Paradigms in Radiation Oncology. Radiation Research 163:1, pages 1-25.
Crossref
Crossref
Nancy Price, G. Kesava Reddy & Vinay K. Jain. (2004) Highlights From: 46th Annual Meeting of the American Society of Hematology, December 2004, San Diego, California. Clinical Lymphoma 5:3, pages 144-148.
Crossref
Crossref
Catherine Burton, Peter Ell & David Linch. (2004) The role of PET imaging in lymphoma. British Journal of Haematology 126:6, pages 772-784.
Crossref
Crossref
Homer A. Macapinlac. (2004) FDG PET and PET/CT Imaging in Lymphoma and Melanoma. The Cancer Journal 10:4, pages 262-270.
Crossref
Crossref
Ralph M. Meyer, Richard F. Ambinder & Sigrid Stroobants. (2004) Hodgkin’s Lymphoma: Evolving Concepts with Implications for Practice. Hematology 2004:1, pages 184-202.
Crossref
Crossref